Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis

TUESDAY, July 23, 2019 -- Among patients with moderately to severely active rheumatoid arthritis (RA) resistant to previous therapy with biologic agents, a significantly higher clinical response rate was seen at 12 weeks for those receiving...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news